Study on the mechanism of oral administration of tetrandrine during neoadjuvant chemotherapy for colon cancer

Li,Dan; Li,Junmei; Yu,Feng; Wang,Bo; Liu,Bing

doi:10.3892/ol.2023.13811

Study on the mechanism of oral administration of tetrandrine during neoadjuvant chemotherapy for colon cancer

Authors:
- Dan Li
- Junmei Li
- Feng Yu
- Bo Wang
- Bing Liu
View Affiliations

Affiliations: School of Pharmacy, Qilu Medical University, Zibo, Shandong 255300, P.R. China, Department of Pharmacy, Dezhou People's Hospital, Dezhou, Shandong 253000, P.R. China, Clinical Laboratory, Qingdao Eighth People's Hospital, Qingdao, Shandong 266100, P.R. China, Dental Department, Qingdao Eighth People's Hospital, Qingdao, Shandong 266100, P.R. China, Pharmacy Intravenous Admixture Service (PIVAS), The First Hospital of Zibo City, Zibo, Shandong 255200, P.R. China
Published online on: April 13, 2023 https://doi.org/10.3892/ol.2023.13811
Article Number: 225

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Colon cancer is a digestive tract tumor with one of the highest frequencies worldwide, and with a high fatality rate. The present study aimed to investigate the expression and regulation of inflammatory factors in tumor tissues, monocytes and blood samples in patients with colon cancer (n=46) following treatment with neoadjuvant chemotherapy combined with tetrandrine. All patients underwent tumor resection after neoadjuvant chemotherapy. In the experimental group, 20 cases took tetrandrine during chemotherapy, while in the control group, 26 cases underwent chemotherapy without tetrandrine. Reverse transcription‑quantitative PCR and western blotting were performed to detect the mRNA and protein expression levels of TNF‑α. ELISA was used to detect the cytokine/chemokine expression levels [IL‑15, IL‑1β and IL‑6, as well as chemokine ligand (CCL)2, CCL5, CCL20, chemokine (C‑X‑C motif) ligand CXCL1, CXCL2, CXCL3, CXCL5 and CXCL10 in the culture supernatant of colon cancer tissue]. Human blood mononuclear cells were cultured, and cytokine release was determined by ELISA. Cell proliferation ability was assessed using the MTT assay. Compared with the control group, the mRNA and protein expression levels of tumor necrosis factor‑α (TNF‑α) were downregulated in tumor tissues and serum and the serum levels of IL‑15, IL‑1β and IL‑6 were relatively low in the experimental group. The expression levels of CCL5, CXCL2 and CXCL10 in the supernatant of cancer tissue culture were relatively low, compared with the conditioned medium prepared from tumor tissues of patients not receiving tetrandrine. When the cultured blood mononuclear cells were stimulated by the tissue culture supernatant from the experimental group, less IL‑15, IL‑1β and IL‑6 were released, compared with the medium of tumor tissues of patients not taking tetrandrine. Following stimulation with the tissue culture supernatant from the experimental group, the proliferation ability of HCT116 colon cancer cells significantly declined. During chemotherapy of patients with colon cancer, tetrandrine may inhibit the expression of TNF‑α in cancer tissues and blood, reduce the release of inflammatory factors and chemokines and decrease cancer cell proliferation. These findings provide a theoretical basis for the treatment of colon cancer in the clinic.

View Figures

View References

1	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
2	Chesney TR, Metz JJ, Nadler A, Quereshy FA, Ashamalla S, Acuna SA and Swallow CJ: Long-term outcomes of resection for locoregional recurrence of colon cancer: A retrospective descriptive cohort study. Eur J Surg Oncol. 47:2390–2397. 2021. View Article : Google Scholar : PubMed/NCBI
3	Haber PK, Puigvehí M, Castet F, Lourdusamy V, Montal R, Tabrizian P, Buckstein M, Kim E, Villanueva A, Schwartz M and Llovet JM: Evidence-based management of Hepatocellular Carcinoma: Systematic review and meta-analysis of randomized controlled trials (2002–2020). Gastroenterology. 161:879–898. 2021. View Article : Google Scholar : PubMed/NCBI
4	Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal A: Colorectal cancer statistics, 2020. CA Cancer J Clin. 70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
5	Thosani N, Guha S and Singh H: Colonoscopy and colorectal cancer incidence and mortality. Gastroenterol Clin North Am. 42:619–637. 2013. View Article : Google Scholar : PubMed/NCBI
6	Nasseri Y and Langenfeld SJ: Imaging for colorectal cancer. Surg Clin North Am. 97:503–513. 2017. View Article : Google Scholar : PubMed/NCBI
7	Simon K: Colorectal cancer development and advances in screening. Clin Interv Aging. 11:967–976. 2016. View Article : Google Scholar : PubMed/NCBI
8	Hon KW, Abu N, Ab Mutalib NS and Jamal R: miRNAs and lncRNAs as predictive biomarkers of response to FOLFOX therapy in colorectal cancer. Front Pharmacol. 9:8462018. View Article : Google Scholar : PubMed/NCBI
9	Wang K and Karin M: Tumor-elicited inflammation and colorectal cancer. Adv Cancer Res. 128:173–196. 2015. View Article : Google Scholar : PubMed/NCBI
10	Candido J and Hagemann T: Cancer-related inflammation. J Clin Immunol. 33 (Suppl 1):S79–S84. 2013. View Article : Google Scholar : PubMed/NCBI
11	Hong H, Jiang L, Lin Y, He C, Zhu G, Du Q, Wang X, She F and Chen Y: TNF-alpha promotes lymphangiogenesis and lymphatic metastasis of gallbladder cancer through the ERK1/2/AP-1/VEGF-D pathway. BMC Cancer. 16:2402016. View Article : Google Scholar : PubMed/NCBI
12	Xiao Z, Liu Q, Mao F, Wu J and Lei T: TNF-α-induced VEGF and MMP-9 expression promotes hemorrhagic transformation in pituitary adenomas. Int J Mol Sci. 12:4165–4179. 2011. View Article : Google Scholar : PubMed/NCBI
13	Tanaka T, Imamura T, Yoneda M, Irie A, Ogi H, Nagata M, Yoshida R, Fukuma D, Kawahara K, Shinohara M and Nakayama H: Enhancement of active MMP release and invasive activity of lymph node metastatic tongue cancer cells by elevated signaling via the TNF-α-TNFR1-NF-κB pathway and a possible involvement of angiopoietin-like 4 in lung metastasis. Int J Oncol. 49:1377–1384. 2016. View Article : Google Scholar : PubMed/NCBI
14	Thanos S and Vanselow J: The effect of central and peripheral neuroglia on the regeneration of the optic nerve. Fortschr Ophthalmol. 86:172–175. 1989.(In German). PubMed/NCBI
15	Olsen RS, Nijm J, Andersson RE, Dimberg J and Wagsater D: Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer. World J Gastroenterol. 23:6212–6219. 2017. View Article : Google Scholar : PubMed/NCBI
16	Mikami S, Mizuno R, Kosaka T, Saya H, Oya M and Okada Y: Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas. Int J Cancer. 136:1504–1514. 2015. View Article : Google Scholar : PubMed/NCBI
17	Sang C, Zhang J, Zhang Y, Chen F, Cao X and Guo L: TNF-α promotes osteoclastogenesis through JNK signaling-dependent induction of Semaphorin3D expression in estrogen-deficiency induced osteoporosis. J Cell Physiol. 232:3396–3408. 2017. View Article : Google Scholar : PubMed/NCBI
18	Aye IL, Jansson T and Powell TL: TNF-α stimulates System A amino acid transport in primary human trophoblast cells mediated by p38 MAPK signaling. Physiol Rep. 3:e125942015. View Article : Google Scholar : PubMed/NCBI
19	Sanchavanakit N, Saengtong W, Manokawinchoke J and Pavasant P: TNF-α stimulates MMP-3 production via PGE2 signalling through the NF-kB and p38 MAPK pathway in a murine cementoblast cell line. Arch Oral Biol. 60:1066–1074. 2015. View Article : Google Scholar : PubMed/NCBI
20	Sedger LM and McDermott MF: TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants-past, present and future. Cytokine Growth Factor Rev. 25:453–472. 2014. View Article : Google Scholar : PubMed/NCBI
21	Xu XH, Gan YC, Xu GB, Chen T, Zhou H, Tang JF, Gu Y, Xu F, Xie YY, Zhao XY and Xu RZ: Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis. J Zhejiang Univ Sci B. 13:867–874. 2012. View Article : Google Scholar : PubMed/NCBI
22	Lyu L, Hu Y, Yin S, Wang L, Ye F, Wang M, Zhou Y, Ma W, Chen C, Jiang Y, et al: Autophagy inhibition enhances anti-pituitary adenoma effect of tetrandrine. Phytother Res. 35:4007–4021. 2021. View Article : Google Scholar : PubMed/NCBI
23	Wang J, Yao Z, Lai X, Bao H, Li Y, Li S, Chang L and Zhang G: Tetrandrine sensitizes nasopharyngeal carcinoma cells to irradiation by inducing autophagy and inhibiting MEK/ERK pathway. Cancer Med. 9:7268–7278. 2020. View Article : Google Scholar : PubMed/NCBI
24	Cho HS, Chang SH, Chung YS, Shin JY, Park SJ, Lee ES, Hwang SK, Kwon JT, Tehrani AM, Woo M, et al: Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. J Vet Sci. 10:23–28. 2009. View Article : Google Scholar : PubMed/NCBI
25	Ye LY, Hu S, Xu HE, Xu RR, Kong H, Zeng XN, Xie WP and Wang H: The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells. Cancer Cell Int. 17:402017. View Article : Google Scholar : PubMed/NCBI
26	Chen Y, Tsai YH and Tseng SH: The potential of tetrandrine as a protective agent for ischemic stroke. Molecules. 16:8020–8032. 2011. View Article : Google Scholar : PubMed/NCBI
27	Xie W and Du L: Diabetes is an inflammatory disease: Evidence from traditional Chinese medicines. Diabetes Obes Metab. 13:289–301. 2011. View Article : Google Scholar : PubMed/NCBI
28	Idec-Sadkowska I, Andrzejak R, Antonowicz-Juchniewicz J and Kaczmarek-Wdowiak B: Trials of casual treatment of silicosis. Med Pr. 57:271–280. 2006.(In Polish). PubMed/NCBI
29	Wang B, Yang L, Yan HL, Wang M and Xiao JG: Effect of tetrandrine on calcium-dependent tumour necrosis factor-alpha production in glia-neurone mixed cultures. Basic Clin Pharmacol Toxicol. 97:244–248. 2005. View Article : Google Scholar : PubMed/NCBI
30	Ferrante A, Seow WK, Rowan-Kelly B and Thong YH: Tetrandrine, a plant alkaloid, inhibits the production of tumour necrosis factor-alpha (cachectin) hy human monocytes. Clin Exp Immunol. 80:232–235. 1990. View Article : Google Scholar : PubMed/NCBI
31	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
32	Lunjani N, Tan G, Dreher A, Sokolowska M, Groeger D, Warwyzniak M, Altunbulakli C, Westermann P, Basera W, Hobane L, et al: Environment-dependent alterations of immune mediators in urban and rural south African children with atopic dermatitis. Allergy. 77:569–581. 2022. View Article : Google Scholar : PubMed/NCBI
33	Wierdak M, Surmiak M, Milian-Ciesielska K, Rubinkiewicz M, Rzepa A, Wysocki M, Major P, Kłęk S and Pędziwiatr M: Immunonutrition changes inflammatory response in colorectal cancer: Results from a pilot randomized clinical trial. Cancers (Basel). 13:14442021. View Article : Google Scholar : PubMed/NCBI
34	Weitzenfeld P, Kossover O, Körner C, Meshel T, Wiemann S, Seliktar D, Legler DF and Ben-Baruch A: Chemokine axes in breast cancer: Factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors. J Leukoc Biol. 99:1009–1025. 2016. View Article : Google Scholar : PubMed/NCBI
35	Chen G, Tang N, Wang C, Xiao L, Yu M, Zhao L, Cai H, Han L, Xie C and Zhang Y: TNF-α-inducing protein of Helicobacter pylori induces epithelial-mesenchymal transition (EMT) in gastric cancer cells through activation of IL-6/STAT3 signaling pathway. Biochem Biophys Res Commun. 484:311–317. 2017. View Article : Google Scholar : PubMed/NCBI
36	Qiao Y, He H, Jonsson P, Sinha I, Zhao C and Dahlman-Wright K: AP-1 is a key regulator of proinflammatory cytokine TNFα-mediated Triple-negative breast cancer progression. J Biol Chem. 291:5068–5079. 2016. View Article : Google Scholar : PubMed/NCBI
37	Strekalova E, Malin D, Good DM and Cryns VL: Methionine deprivation induces a targetable vulnerability in triple-negative breast cancer cells by enhancing TRAIL receptor-2 expression. Clin Cancer Res. 21:2780–2791. 2015. View Article : Google Scholar : PubMed/NCBI
38	Lebrec H, Ponce R, Preston BD, Iles J, Born TL and Hooper M: Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk. Curr Med Res Opin. 31:557–574. 2015. View Article : Google Scholar : PubMed/NCBI
39	Stamova S, Ott-Rötzer B, Smetak H, Schäffler K, Eder R, Fink I, Hoffmann P, Reichert TE, Beckhove P and Spanier G: Characterization and ex vivo expansion of rare in situ cytokine secreting T cell populations from tumor tissue and blood of oral squamous cell carcinoma patients. J Immunol Methods. 496:1130862021. View Article : Google Scholar : PubMed/NCBI
40	Pilling AB, Hwang O, Boudreault A, Laurent A and Hwang C: IAP Antagonists enhance apoptotic response to enzalutamide in castration-resistant prostate cancer cells via autocrine TNF-α Signaling. Prostate. 77:866–877. 2017. View Article : Google Scholar : PubMed/NCBI
41	Lee J, Tian Y, Chan ST, Kim JY, Cho C and Ou JH: TNF-α induced by hepatitis C Virus via TLR7 and TLR8 in hepatocytes supports interferon signaling via an autocrine mechanism. PLoS Pathog. 11:e10049372015. View Article : Google Scholar : PubMed/NCBI
42	Li P, Zou J, Dong Y, Jiang J, Liang W and Li D: Tetrandrine, a potent antifungal agent: Inhibits mycelial growth and virulence of Botrytis cinerea. Phytopathology. 111:1152–1157. 2021. View Article : Google Scholar : PubMed/NCBI
43	Serag El-Dien MM, Abdou AG, Asaad NY, Abd El-Wahed MM and Kora MAEM: Intratumoral FOXP3+ regulatory T cells in diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol. 25:534–542. 2017. View Article : Google Scholar : PubMed/NCBI
44	Liu JY, Feng CP, Li X, Chang MC, Meng JL and Xu LJ: Immunomodulatory and antioxidative activity of Cordyceps militaris polysaccharides in mice. Int J Biol Macromol. 86:594–598. 2016. View Article : Google Scholar : PubMed/NCBI
45	Zhao H, Kong L, Shen J, Ma Y, Wu Z, Li H and He Y: Tetrandrine inhibits the occurrence and development of frozen shoulder by inhibiting inflammation, angiogenesis, and fibrosis. Biomed Pharmacother. 140:1117002021. View Article : Google Scholar : PubMed/NCBI
46	Eapen MS, Hansbro PM, Larsson-Callerfelt AK, Jolly MK, Myers S, Sharma P, Jones B, Rahman MA, Markos J, Chia C, et al: Chronic obstructive pulmonary disease and lung cancer: Underlying pathophysiology and new therapeutic modalities. Drugs. 78:1717–1740. 2018. View Article : Google Scholar : PubMed/NCBI
47	Dai P, Li J, Ma XP, Huang J, Meng JJ and Gong P: Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: A meta-analysis. Onco Targets Ther. 11:721–730. 2018. View Article : Google Scholar : PubMed/NCBI
48	Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, Morabito N, Lasco A, Gangemi S and Basile G: Inflammaging and anti-inflammaging: The role of cytokines in extreme longevity. Arch Immunol Ther Exp (Warsz). 64:111–126. 2016. View Article : Google Scholar : PubMed/NCBI
49	Feng L, Qi Q, Wang P, Chen H, Chen Z, Meng Z and Liu L: Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer. J Int Med Res. 46:5228–5236. 2018. View Article : Google Scholar : PubMed/NCBI
50	Manohar M, Kandikattu HK, Verma AK and Mishra A: IL-15 regulates fibrosis and inflammation in a mouse model of chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol. 315:G954–G965. 2018. View Article : Google Scholar : PubMed/NCBI
51	Lee CH, Chang JS, Syu SH, Wong TS, Chan JY, Tang YC, Yang ZP, Yang WC, Chen CT, Lu SC, et al: IL-1β promotes malignant transformation and tumor aggressiveness in oral cancer. J Cell Physiol. 230:875–884. 2015. View Article : Google Scholar : PubMed/NCBI
52	Cabrero-de Las Heras S and Martinez-Balibrea E: CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer. World J Gastroenterol. 24:4738–4749. 2018. View Article : Google Scholar : PubMed/NCBI
53	Itatani Y, Kawada K, Inamoto S, Yamamoto T, Ogawa R, Taketo MM and Sakai Y: The role of chemokines in promoting colorectal cancer invasion/metastasis. Int J Mol Sci. 17:6432016. View Article : Google Scholar : PubMed/NCBI